Proton Pump Inhibitors—We Know Their Benefits, But What Are Their Risks? - Frankly Speaking Ep 316

Release Date:

Credits: 0.25 AMA PRA Category 1 Credit™
 
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-316
Overview: While the benefits of proton pump inhibitors (PPIs) are widely known, the same cannot be said of the risks. These common medications are generally considered “safe,” but new data suggest the potential for long-term risks. Join us to discuss these long-term risks of PPI use and whether some of your patients should step down from PPIs to H2RAs. 
Episode resource links:
Gut : 28 September 2020. doi: 10.1136/gutjnl-2020-322557
Gut 2022 Jan; 71:16. (https://doi.org/10.1136/gutjnl-2021-325097)
Front Pharmacol. 2022 Sep 14;13:979215. doi: 10.3389/fphar.2022.979215. eCollection 2022

Guest: Jill M. Terrien PhD, ANP-BC 
 
Music Credit: Richard Onorato

Proton Pump Inhibitors—We Know Their Benefits, But What Are Their Risks? - Frankly Speaking Ep 316

Title
Proton Pump Inhibitors—We Know Their Benefits, But What Are Their Risks? - Frankly Speaking Ep 316
Copyright
Release Date

flashback